Is Bath & Body Works (BBWI) Undervalued On Activist Pressure For A Sale?

Activist pressure puts Bath & Body Works in play

Barington Capital Group has taken an activist stake in Bath & Body Works (BBWI), calling for a potential sale, advocating for share repurchases, and seeking board seats to address what it describes as undervaluation and management instability.

Bath & Body Works shares closed at US$17.19, with the 1 day share price return of 2.75% only partially offsetting a 30 day share price decline of 14.22% and a 1 year total shareholder return that is down 31.78%. This suggests the activist campaign is landing on a stock where momentum has been fading and investor sentiment has already weakened.

Scan how activists, turnarounds, and other potential value plays like Bath & Body Works stack up in our curated list of 29 high quality undervalued stocks.

Bath & Body Works trades around US$17 while analyst targets and some fair value estimates sit materially higher. Is that a genuine discount, or a warning sign that the market’s caution on this retailer is warranted?

Most Popular Narrative: 57% Undervalued

Against Bath & Body Works' last close at $17.19, the most followed valuation story pegs fair value far higher at $39.78. This frames the activist interest against a thesis that the equity is materially mispriced.

BBW is set to renegotiate leases over time. Favorably updated rent agreements, new off-mall locations, and productivity gains from the White Barn format conversion could help boost profits.

See why 24 investors see Bath & Body Works as 57% undervalued.

According to julio, the narrative assumes a 6.0% revenue growth rate, a 12.0% profit margin and applies a 10.0x future P/E multiple, all discounted at 9.0%. That framework produces a fair value estimate of $39.78 per share, which implies a discount of 56.8% relative to that model.

That gap is much wider than the 31.5% discount to the SWS DCF model's future cash flow value of $25.11 highlighted in the screening data and also meaningfully above the roughly 40% discount to the current analyst target price of $24.06. For an investor assessing Bath & Body Works, the question is whether the lease renegotiation, loyalty program scale and category expansion outlined in the thesis can justify the higher narrative fair value or whether the smaller discounts implied by other reference points better capture the risks around debt, slower forecast growth and negative equity.

Result: Fair Value of $39.78 (UNDERVALUED)

Still, Bath & Body Works has significant mall exposure and faces rapidly changing consumer tastes, either of which could weaken the bullish lease and loyalty thesis.

Find out about the key risks to this Bath & Body Works narrative.

Next Steps

Sentiment around Bath & Body Works is split, with activists leaning bullish while recent returns reflect clear caution, so consider acting promptly and weigh the evidence yourself by looking through the 2 key rewards and 3 important warning signs.

Looking for more Bath & Body Works investment ideas?

If Bath & Body Works has you thinking about mispricing and opportunity, do not stop here. Broaden your watchlist and compare alternatives before the market wakes up.

• Target dependable cash generators by scanning our 6 dividend fortresses that might complement a consumer-focused holding like Bath & Body Works.
• Spot potential bargains quickly when you review the wider universe of 29 high quality undervalued stocks that share traits with activist situations and turnarounds.
• Shield your portfolio from concentration risk by balancing with a 30 resilient stocks with low risk scores that could offset volatility in retail and other cyclical areas.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com